Patrick J Lustman
Overview
Explore the profile of Patrick J Lustman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
2046
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Salas J, Miller M, Scherrer J, Moore R, McCrae C, Sullivan M, et al.
J Opioid Manag
. 2020 Nov;
16(5):317-328.
PMID: 33226089
Objective: Insomnia commonly co-occurs with depression, chronic pain, and opioid use. Both insomnia and chronic opioid analgesic use (OAU) are independent risk factors for a new depression episode (NDE). This...
12.
Salas J, Norman S, Tuerk P, van den Berk-Clark C, Cohen B, Schneider F, et al.
Drug Alcohol Depend
. 2020 Oct;
218:108365.
PMID: 33109460
Background: Clinical trials reveal posttraumatic stress disorder (PTSD) improvement leads to decreased substance use among patients with comorbid substance use disorder (SUD). Using administrative medical record data, we determined whether...
13.
Scherrer J, Salas J, Grucza R, Sullivan M, Lustman P, Copeland L, et al.
J Affect Disord
. 2020 Oct;
278:563-569.
PMID: 33022442
Background: Depression occurs in 40% of patients with prescription opioid dependence (POD). Existing studies of the association between depression and buprenorphine (BUP) treatment for POD are inconsistent and often include...
14.
Scherrer J, Ahmedani B, Autio K, DeBar L, Lustman P, Miller-Matero L, et al.
J Psychiatr Brain Sci
. 2020 Jun;
5.
PMID: 32542189
Background: Results from studies using medical record data indicate chronic (>90 days) opioid analgesic use (OAU) is associated with new depressive episodes (NDE), worsening depression and risk for depression recurrence....
15.
Scherrer J, Salas J, Schneider F, Friedman M, van den Berk-Clark C, Chard K, et al.
J Psychosom Res
. 2020 May;
134:110128.
PMID: 32403058
Background: Posttraumatic stress disorder (PTSD) is associated with increased risk for cardiovascular disease (CVD). Whether clinically meaningful PTSD improvement is associated with lowering CVD risk is unknown. Methods: Eligible patients...
16.
Scherrer J, Lustman P
Chronic Stress (Thousand Oaks)
. 2020 May;
3.
PMID: 32395677
No abstract available.
17.
Scherrer J, Salas J, Friedman M, Cohen B, Schneider F, Lustman P, et al.
Health Psychol
. 2020 Apr;
39(5):403-412.
PMID: 32223280
Objective: Posttraumatic stress disorder (PTSD) is associated with increased risk for cardiometabolic disease. Clinically meaningful PTSD improvement is associated with a lower risk for diabetes, but it is not known...
18.
Scherrer J, Salas J, Chard K, Tuerk P, van den Berk-Clark C, Schneider F, et al.
J Psychosom Res
. 2019 Oct;
127:109849.
PMID: 31654900
Objective: Posttraumatic stress disorder (PTSD) is associated with poor health behaviors, including low utilization of Veteran Health Affairs (VHA) weight loss programs. It is not known if clinically meaningful PTSD...
19.
Scherrer J, Salas J, Norman S, Schnurr P, Chard K, Tuerk P, et al.
JAMA Psychiatry
. 2019 Aug;
76(11):1159-1166.
PMID: 31433443
Importance: Posttraumatic stress disorder (PTSD) is associated with increased risk of type 2 diabetes (T2D). Improvement in PTSD has been associated with improved self-reported physical health and hypertension; however, there...
20.
Gilliam F, Black K, Carter J, Freedland K, Sheline Y, Tsai W, et al.
Ann Neurol
. 2019 Jul;
86(4):552-560.
PMID: 31359460
Objective: Limited evidence is available to guide treatment of depression for persons with epilepsy. We evaluated the comparative effectiveness of sertraline and cognitive behavior therapy (CBT) for depression, quality of...